Centogene nominates Dr. Andreas Busch for election to its Supervisory Board
– GERMANY, Rostock – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the nomination of Dr.…